BioNTech SE (NAS:BNTX)
$ 110.64 2.76 (2.56%) Market Cap: 26.52 Bil Enterprise Value: 8.25 Bil PE Ratio: 0 PB Ratio: 1.25 GF Score: 68/100

Q2 2023 BioNTech SE Earnings Call Transcript

Aug 07, 2023 / 12:00PM GMT
Release Date Price: $98.5 (-7.49%)
Operator

Welcome to BioNTech Second Quarter 2023 Update Call. I would like to hand the call over to Dr. Victoria Meissner, Vice President of Strategy and Investor Relations. Please go ahead.

Victoria Meissner

Thank you. Good morning and afternoon. Thank you for joining us today for BioNTech's Second Quarter 2023 Earnings Call. As a brief reminder, the slides to accompany this call and the second quarter 2023 press release that was issued this morning can be found in the Investors section of our website. As outlined on Slide 2, you can see all our forward-looking statements disclaimer.

Additional information about the statements and other risks are described in our filings made with the U.S. Securities and Exchange Commission. Forward-looking statements in the call are subject to substantial risks and uncertainties. We speak only as of the call's original date, and we undertake no obligation to update or revise any of these statements.

On Slide 3, you can find the agenda for today's call. Today, I'm joined by the following members of BioNtech's management

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot